Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study.

Gajos A, Budrewicz S, Koszewicz M, Bieńkiewicz M, Dąbrowski J, Kuśmierek J, Sławek J, Bogucki A.

J Neural Transm (Vienna). 2017 Nov;124(11):1389-1393. doi: 10.1007/s00702-017-1780-1. Epub 2017 Aug 23.

2.

Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts.

Jędrak P, Krygier M, Tońska K, Drozd M, Kaliszewska M, Bartnik E, Sołtan W, Sitek EJ, Stanisławska-Sachadyn A, Limon J, Sławek J, Węgrzyn G, Barańska S.

Metab Brain Dis. 2017 Aug;32(4):1237-1247. doi: 10.1007/s11011-017-0026-0. Epub 2017 May 16.

3.

Drawing analysis in the assessment of patients with neurodegenerative diseases.

Sitek EJ, Narożańska E, Konieczna S, Brockhuis B, Wieczorek D, Wszolek ZK, Sławek J.

Neurology. 2017 Jan 10;88(2):218-219. doi: 10.1212/WNL.0000000000003496. No abstract available.

4.

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.

PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.

5.

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.

Hauser RA, Slawek J, Barone P, Dohin E, Surmann E, Asgharnejad M, Bauer L.

BMC Neurol. 2016 Jun 7;16:90. doi: 10.1186/s12883-016-0610-7.

6.

Genomic instability in the PARK2 locus is associated with Parkinson's disease.

Ambroziak W, Koziorowski D, Duszyc K, Górka-Skoczylas P, Potulska-Chromik A, Sławek J, Hoffman-Zacharska D.

J Appl Genet. 2015 Nov;56(4):451-461. doi: 10.1007/s13353-015-0282-9. Epub 2015 Apr 2.

7.

Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation--a 5 year follow up.

Schinwelski M, Kierdaszuk B, Dulski J, Tońska K, Kodroń A, Sitek EJ, Bartnik E, Kamińska A, Kwieciński H, Sławek J.

Metab Brain Dis. 2015 Aug;30(4):1083-5. doi: 10.1007/s11011-014-9645-x. Epub 2014 Dec 31.

8.

Neuroimaging in the differential diagnosis of primary progressive aphasia - illustrative case series in the light of new diagnostic criteria.

Sitek EJ, Narożańska E, Brockhuis B, Muraszko-Klaudel A, Lass P, Harciarek M, Sławek J.

Pol J Radiol. 2014 Aug 8;79:251-8. doi: 10.12659/PJR.890320. eCollection 2014.

9.

ENNET: inferring large gene regulatory networks from expression data using gradient boosting.

Sławek J, Arodź T.

BMC Syst Biol. 2013 Oct 22;7:106. doi: 10.1186/1752-0509-7-106.

10.

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.

Sitek EJ, Narożańska E, Pepłońska B, Filipek S, Barczak A, Styczyńska M, Mlynarczyk K, Brockhuis B, Portelius E, Religa D, Barcikowska M, Sławek J, Żekanowski C.

PLoS One. 2013 Apr 12;8(4):e61074. doi: 10.1371/journal.pone.0061074. Print 2013.

11.

Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

Sitek EJ, Narozanska E, Barczak A, Jasinska-Myga B, Harciarek M, Chodakowska-Zebrowska M, Kubiak M, Wieczorek D, Konieczna S, Rademakers R, Baker M, Berdynski M, Brockhuis B, Barcikowska M, Zekanowski C, Heilman KM, Wszolek ZK, Slawek J.

Neurocase. 2014;20(1):69-86. doi: 10.1080/13554794.2012.732087. Epub 2012 Nov 5.

12.

Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.

Wray S, Self M; NINDS Parkinson's Disease iPSC Consortium; NINDS Huntington's Disease iPSC Consortium; NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Preza E, Barker S, Sutherland M, Corriveau RA, D'Andrea M, Schapira AH, Uitti RJ, Guttman M, Opala G, Jasinska-Myga B, Puschmann A, Nilsson C, Espay AJ, Slawek J, Gutmann L, Boeve BF, Boylan K, Stoessl AJ, Ross OA, Maragakis NJ, Van Gerpen J, Gerstenhaber M, Gwinn K, Dawson TM, Isacson O, Marder KS, Clark LN, Przedborski SE, Finkbeiner S, Rothstein JD, Wszolek ZK, Rossor MN, Hardy J.

PLoS One. 2012;7(8):e43099. doi: 10.1371/journal.pone.0043099. Epub 2012 Aug 27.

13.

Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Banaszkiewicz K, Sitek EJ, Rudzińska M, Sołtan W, Sławek J, Szczudlik A.

J Neural Transm (Vienna). 2012 Nov;119(11):1361-5. doi: 10.1007/s00702-012-0787-x. Epub 2012 Mar 8.

14.

PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G, Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, Opala G, Drozdzik M, Nishioka K, Farrer MJ, Ross OA, Wszolek ZK, Barcikowska M, Zekanowski C.

Parkinsonism Relat Disord. 2012 Jun;18(5):520-4. doi: 10.1016/j.parkreldis.2012.01.021. Epub 2012 Feb 22.

15.

Automatic assessment of the motor state of the Parkinson's disease patient--a case study.

Kostek B, Kaszuba K, Zwan P, Robowski P, Slawek J.

Diagn Pathol. 2012 Feb 19;7:18. doi: 10.1186/1746-1596-7-18.

16.

Assessing self-awareness of dyskinesias in Parkinson's disease through movie materials.

Sitek EJ, Soltan W, Wieczorek D, Robowski P, Schinwelski M, Slawek J.

Funct Neurol. 2011 Jul-Sep;26(3):121-6.

17.

Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.

Narożańska E, Jasińska-Myga B, Sitek EJ, Robowski P, Brockhuis B, Lass P, Dubaniewicz M, Wieczorek D, Baker M, Rademakers R, Wszolek ZK, Sławek J.

Eur J Neurol. 2011 Mar;18(3):535-7. doi: 10.1111/j.1468-1331.2010.03107.x.

Supplemental Content

Loading ...
Support Center